Tag: Hepatitis C treatment

Meeting people where they are is about much more than location: Delivering hepatitis C care and treatment to people who use drugs

Poverty, stigma and criminalization are chronic problems among people who use and inject drugs. But hepatitis C virus (HCV) is no longer such a problem, since it is usually cured by eight to 12 weeks of oral, direct-acting antivirals (DAAs). Delivering DAAs to people who use and inject drugs in the context of the chronic problems facing them is an opportunity to recognize and support the contribution of people with lived experience, and to build and strengthen systems and programs.

Read more

Blueprint for Hepatitis C Elimination in Canada: A priority populations and health equity approach – Part One

An introduction by Dr. Jordan Feld, University Health Network Nearly 250,000 Canadians are living with hepatitis C (HCV), yet 45% are undiagnosed and remain at risk of developing complications related to long-term liver damage like liver cancer. Hepatitis C causes more years of life lost than any other infectious disease in Canada. Fortunately, with the arrival of safe treatment that cures more than 95% of people, combined with simple diagnostic methods and effective prevention strategies, we now have the tools to eliminate hepatitis C.

Read more

Hepatitis C elimination in Canada: Five approaches to make it happen

Canada is one of 194 countries that have signed on to the World Health Organization’s Global Health Sector Strategy on Viral Hepatitis, committing to eliminate hepatitis C as a public health threat by 2030. The wide availability of a cure for all Canadians, along with new tools to prevent and diagnose hepatitis C, mean that elimination is now possible for the first time. This year, new research and examples from other countries have shown how we can approach an elimination strategy, and Canada has started to build momentum. Here are five approaches that we can adopt to make hepatitis C...

Read more